Jacksonville, Florida, United States
Contact Info
524 followers
500+ connections
Activity
-
We are pleased to announce the commercial launch and availability of our sprinkle formulation for the treatment of tardive dyskinesia and chorea…
We are pleased to announce the commercial launch and availability of our sprinkle formulation for the treatment of tardive dyskinesia and chorea…
Liked by Amy Schemer
-
I am proud to announce the start of a new and exciting opportunity for me at Cybin. This builds on a long-standing interest of mine (dating back…
I am proud to announce the start of a new and exciting opportunity for me at Cybin. This builds on a long-standing interest of mine (dating back…
Liked by Amy Schemer
Experience
Education
More activity by Amy
-
Love working for IQVIA where transformation and innovation are part of our DNA.
Love working for IQVIA where transformation and innovation are part of our DNA.
Liked by Amy Schemer
-
Today is Glioblastoma Awareness Day and I am thinking about those friends and people who have been devastated with what is often a terminal…
Today is Glioblastoma Awareness Day and I am thinking about those friends and people who have been devastated with what is often a terminal…
Liked by Amy Schemer
-
An exciting day for us at MindMed! We're thrilled to announce the issuance of a new patent covering the pharmaceutical formulation for our MM120…
An exciting day for us at MindMed! We're thrilled to announce the issuance of a new patent covering the pharmaceutical formulation for our MM120…
Liked by Amy Schemer
-
We are pleased to announce the U.S. FDA has accepted our two New Drug Applications (NDAs) with a Priority Review designation for an investigational…
We are pleased to announce the U.S. FDA has accepted our two New Drug Applications (NDAs) with a Priority Review designation for an investigational…
Liked by Amy Schemer
-
With decades of experience and a passion for excellence, our team of experts is committed to leveraging scientific rigor and operational expertise to…
With decades of experience and a passion for excellence, our team of experts is committed to leveraging scientific rigor and operational expertise to…
Liked by Amy Schemer
-
Wow what amazing speakers and moderators we had for 2 days at our 1st opTImize Trial Interactive user summit! Inspection readiness, regulatory…
Wow what amazing speakers and moderators we had for 2 days at our 1st opTImize Trial Interactive user summit! Inspection readiness, regulatory…
Liked by Amy Schemer
-
This Lancet article addresses the immense growth of oncology research in China from 2011-2021, but there is still a numbers gap compared to the US…
This Lancet article addresses the immense growth of oncology research in China from 2011-2021, but there is still a numbers gap compared to the US…
Liked by Amy Schemer
-
Annovis Bio invites you to an investor webcast on July 2, 2024, at 4:30pm ET. We'll discuss recent #buntanetap advancements from Phase III…
Annovis Bio invites you to an investor webcast on July 2, 2024, at 4:30pm ET. We'll discuss recent #buntanetap advancements from Phase III…
Liked by Amy Schemer
-
What an incredible time we had last night at our Community Meetup in San Diego! We are grateful to have been joined by so many remarkable…
What an incredible time we had last night at our Community Meetup in San Diego! We are grateful to have been joined by so many remarkable…
Liked by Amy Schemer
Other similar profiles
-
Dan Kearney
Connect -
Carlos E. Orantes
Connect -
Taylor Lucier Beach
Director of Business Development
Connect -
Lauren White
Connect -
Chelsea Cornelison, MBA
Connect -
Nancy Walton
Rn at CMHC
Connect -
Michael Johnson
physician at Sarkis Family Psychiatry
Connect -
Dolores DiGaetano
Investigator at CNS Healthcare
Connect -
Daniel Owh M.Ed.
Teacher at ABC Unified School District
Connect -
David Kofalt
Product Analyst/APA Style Expert - APA Publishing
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More